EP0773928A1 - 2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis - Google Patents

2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis

Info

Publication number
EP0773928A1
EP0773928A1 EP95927711A EP95927711A EP0773928A1 EP 0773928 A1 EP0773928 A1 EP 0773928A1 EP 95927711 A EP95927711 A EP 95927711A EP 95927711 A EP95927711 A EP 95927711A EP 0773928 A1 EP0773928 A1 EP 0773928A1
Authority
EP
European Patent Office
Prior art keywords
formula
group
azetidinon
esters
butenoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95927711A
Other languages
German (de)
French (fr)
Inventor
Gianfranco Cainelli
Michele Contento
Marco Da Col
Leone Dall'asta
Mauro Panunzio
Irene Resta
Sergio Sandri
Achille Umani Ronchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biochimica Opos SpA
Original Assignee
Biochimica Opos SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochimica Opos SpA filed Critical Biochimica Opos SpA
Publication of EP0773928A1 publication Critical patent/EP0773928A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention concerns novel esters of 2-(2-azetidinon-N- yl)-2 and 3-butenoic acids, a process for their preparation and their use for manufacturing cephem derivatives unsubstituted in the 3- position.
  • Methods for the preparation of cephem derivatives unsubstituted in the 3-position are described in the literature. For example a series of reactions starting from penicillin G through its degradation is described by S. Kukolja et al. in Chemistry and Biology of ⁇ - actam
  • X represents an acylamino group
  • Y represent s a S- substituted dithio group or a sul fonylthio group
  • X and Y together, form a group ( a)
  • the acylamino group represented by X is a group of structure (b) R 1 -CO-NH- (b) in which R represents a phenyl, phenoxymethyl or benzyl radical, unsubstituted or substituted on the benzene ring with one or two atoms of a halogen, preferably chlorine, with one or two alkyl groups of from 1 to 4 carbon atoms, preferably methyl, or with one or two alkoxy groups containing from 1 to 4 carbon atoms, preferably methoxy.
  • R of the above mentioned group (a) has preferably the hereinabove defined meaning.
  • the carboxy-protecting group represented by R may be an ester group selected among the unsubstituted or substituted (C--C. )alkyl, unsubstituted or substituted phenyl, unsubstituted or on the aromatic ring substituted benzyl, or diphenylmethyl groups.
  • R represents phenyl, 4-methylphenyl, 2-methylphenyl, 4- chlorophenyl, benzyl, 4-methylbenzyl, 4-methoxybenzyl, phenoxymethyl,
  • R represents methyl, ethyl, t-butyl, 2,2,2-trichloroethyl, penta luorophenyl, penta chlorophenyl, benzyl, 4-methoxybenzyl, 4-nitrobenzyl, diphenylmethyl.
  • the S-substituted dithio group is preferably represented by the radical (c) of structure
  • R is a unsubstituted or substituted phenyl or a unsubstituted or substituted heterocyclic group.
  • R advantageously represents a phenyl; a phenyl substituted with a (C.- C.)alkyl, preferably methyl, with one or two atoms of a halogen, preferably chlorine, with a nitro group or with a (C..-C.)alkoxy group, preferably methoxy; a 1-naphthyl; a 2-naphthyl; a 6-methoxy-2- naphthyl; a 4-biphenylyl; a 2-benzimidazolyl; a 2-benzothiazolyl; a 2- indolyl; a 3-indolyl; a 2-(1-methyl)indolyl; a l-methyl-3-indolyl.
  • the sulfonylthio group is preferably represented by the radical (d)
  • R is a (C.-C,)alkyl, an unsubstituted or substituted aryl or a unsubstituted or substituted heterocyclic group.
  • R advantageously represents methyl, ethyl, n-propyl, n-butyl, phenyl, phenyl substituted with a (C,-C ⁇ )alkyl, with a (C,-C.)alkoxy group, with a halogen or with a nitro group, 1-naphthyl, 2-naphthyl.
  • the preferred sulfonylthio group is a radical of structure (d) in which R is p-methylphenyl, p-chlorophenyl, p-nitrophenyl or phenyl.
  • the employed solvent may be a polar aprotic derivative such as N,N-dimethylacetamide, N,N-dimethylformamide, dimethylsulfoxide, acetonitrile and the like.
  • the base is used in eguimolecular amounts, but an excess in respect of the azetidinone II does not modify the course of the reaction.
  • the employed base may be organic or inorganic, for example trimethylamine, triethylamine, N-methylmorpholine, N-methylpiperidine, N-benzyltrj. methyla ⁇ monium hydroxide (hereinbelow designated Triton B), sodium hydride, sodium acetate.
  • the 2-azetidinones of formula II used as starting material for the preparation of the compounds of the present invention are known in the literature and can be prepared using well known methods.
  • novel esters of the 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I are key intermediates for the preparation of cephem derivatives unsubst ituted in the 3-position .
  • the present invention also provides the use of compounds of formula I above, wherein X represents a group of the structure (b) , for the preparation of cephem derivatives unsubstituted in the 3-position of formula IV
  • esters of the 2-(2-azetidinon-N-yl)-2- and 3- butenoic acids of formula I are subjected to a cyclization reaction.
  • the compounds of formula I, wherein X and Y, together, form a group (a) are firstly treated with an excess of 2-benzothiazolylsulfenyl chloride in dioxane/water at room temperature or with a slight excess of 2-benzothiazolyl disulfide in tetrahydrofurane in the presence of an aqueous acid such as 5% hydrochloric acid, 25+30% p-toluene sulfonic acid or 10+20% perchloric acid, still at room temperature, to obtain a compound of formula V
  • X represents an acylamino group, more particularly a group of
  • R represents a carboxy-protecting group and Z represents hydrogen, methyl, chloro or nitro.
  • R represents a carboxy-protecting group and Z represents hydrogen, methyl, chloro or nitro.
  • the compound of formula I, wherein X and Y, together, form a group of structure (a) is treated with benzenesulfonyl bromide, p- toluenesulfonyl bromide or p-nitrobenzenesulfonyl bromide in a solvent such as methanol, acetone, tetrahydrofurane, methylene chloride or their mixtures at a temperature of 10+15°C to obtain the corresponding
  • the cyclization occurs in a polar aprotic solvent such as dimethylformamide, or in a ether solvent such as tetrahydrofurane or dioxane, by using a base such as gaseous ammonia, sodium or potassium acetate, triethylamine, sodium or potassium carbonate or bicarbonate, sodium or potassium hydroxide, 1,5-diazabicyclot5.4.0]undec-5-ene o tetramethylguanidine.
  • a base such as gaseous ammonia, sodium or potassium acetate, triethylamine, sodium or potassium carbonate or bicarbonate, sodium or potassium hydroxide, 1,5-diazabicyclot5.4.0]undec-5-ene o tetramethylguanidine.
  • the compounds of formula I wherein X represents an acylamino group, particularly a group of structure (b), and Y represents a sulfonylthio group, more particularly a group of structure (d) , and preferably the compounds of formula VII are straightforward transformed into the corresponding cefem derivatives, unsubstituted in the 3-position, by treatment with a base, as set forth for the compounds of formula V.
  • a 2-azetidinone of formula II wherein X represents a group of structure (b), is used, in order to obtain a cephem derivative, unsubstituted in the 3-position, of formula IV as final product.
  • X represents a group of structure (b)
  • a solution of 0.52 ml of benzyl alcohol and 1.39 ml of triethylami. ne in 5 ml of anhydrous ethyl ether is prepared at -78°C and under argon. After a 10-minute stirring, a solution of 1.38 g of 2-bromo-3- butenoyl chloride in 5 ml of anhydrous ethyl ether is added dropwise. After a 1-hour stirring the reaction mixture is treated with 5 ml of diluted HC1 (1:1 v/v);the aqueous phase is separated and extracted with 10 ml of ethyl ether. The combined ethereal phases are evaporated under vacuum to an oil.
  • the residual oil is purified by chromatography on a silica gel colomn, eluted with methylene chloride/ethyl acetate (3:1 v/v). The collected fractions are evaporated to obtain 1.44 g of the desired product.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula (I), wherein X is an acylamino group, Y is a S-substituted dithio group or a sulfonylthio group, or X and Y are joined to form a group (a), wherein R1 is the aliphatic, aromatic or arylaliphatic residue bound to the carbonyl of said acylamino group and R2 represents a carboxy-protecting group. The compounds (I) are intermediates in the preparation of cephem derivatives unsubstituted in the 3-position.

Description

"2-(2-AZE-Tm-D WI-YL)-2- AND 3-BUI-ENDIC ACIDS DERIVAT-I-VES AMD THEIR USE IN THE CEFHA
-U---6P0R----N-I SYN-M-SCS"
The present invention concerns novel esters of 2-(2-azetidinon-N- yl)-2 and 3-butenoic acids, a process for their preparation and their use for manufacturing cephem derivatives unsubstituted in the 3- position. Methods for the preparation of cephem derivatives unsubstituted in the 3-position are described in the literature. For example a series of reactions starting from penicillin G through its degradation is described by S. Kukolja et al. in Chemistry and Biology of β- actam
Antibiotics, Ed. Morin and Gorman, 1982, Vol.l, pages 170-176, who, in their turn, refer to Helv. Chim. Acta, 1972, pages 423 and following.
A decarbonylation of the corresponding 3-formylcephem is described in Helv. Chim. Acta, 1974, pages 2044 and following. The reduction of
3-hydroxy-3-cephems with sodium borohydride and further dehydratation is illustrated in Helv. Chim. Acta, 1974, pages 1919 and following, whilst a reduction to 3-cephem unsubstituted in the 3-position of 3- chloro, -bromo or -sulfonyloxy derivatives with zinc and acids is described in DE 2.651.595.
However, all the known methods have drawbacks due to the number of steps to arrive to the desired compound or to the obtention of mixtures of [_ 2 and [_3 derivatives.
It has now been found that the cephem derivatives unsubstituted in the 3-position can be obtained in one or two steps only, starting from a 2-azetidinone via novel intermediates.
It has also been found that, by reacting said 2-azetidinone with an ester of 2-bromo-3-butenoic acid in the presence of a base, an acylation is performed in high yields.
Finally, it has been found that the novel intermediates obtained by said alkylation allow the obtention of cephem derivatives unsubstituted in the 3-position in high yields. Thus, it is an object of the present invention to provide novel esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I
wherein the dotted lines indicate a double bond in the 2- or 3- pos it ion, X represents an acylamino group, Y represent s a S- substituted dithio group or a sul fonylthio group , or X and Y , together, form a group ( a)
in which R represents the residue bond to the carbonyl of X and R represents a carboxy-protecting group. The compounds of formula I above are designated as "2 and 3
2 -3 butenoic acids" because they appear as mixtures of [_ and derivatives.
Preferably, the acylamino group represented by X is a group of structure (b) R1-CO-NH- (b) in which R represents a phenyl, phenoxymethyl or benzyl radical, unsubstituted or substituted on the benzene ring with one or two atoms of a halogen, preferably chlorine, with one or two alkyl groups of from 1 to 4 carbon atoms, preferably methyl, or with one or two alkoxy groups containing from 1 to 4 carbon atoms, preferably methoxy. Thus, the radical R of the above mentioned group (a) has preferably the hereinabove defined meaning.
2 The carboxy-protecting group represented by R may be an ester group selected among the unsubstituted or substituted (C--C. )alkyl, unsubstituted or substituted phenyl, unsubstituted or on the aromatic ring substituted benzyl, or diphenylmethyl groups.
Preferably R represents phenyl, 4-methylphenyl, 2-methylphenyl, 4- chlorophenyl, benzyl, 4-methylbenzyl, 4-methoxybenzyl, phenoxymethyl,
2 4-methylphenoxymethyl, 4-chlorophenoxymethyl, and R represents methyl, ethyl, t-butyl, 2,2,2-trichloroethyl, penta luorophenyl, penta chlorophenyl, benzyl, 4-methoxybenzyl, 4-nitrobenzyl, diphenylmethyl.
The S-substituted dithio group is preferably represented by the radical (c) of structure
-S-S-R3 (c) in which R is a unsubstituted or substituted phenyl or a unsubstituted or substituted heterocyclic group. In the radical (c) R advantageously represents a phenyl; a phenyl substituted with a (C.- C.)alkyl, preferably methyl, with one or two atoms of a halogen, preferably chlorine, with a nitro group or with a (C..-C.)alkoxy group, preferably methoxy; a 1-naphthyl; a 2-naphthyl; a 6-methoxy-2- naphthyl; a 4-biphenylyl; a 2-benzimidazolyl; a 2-benzothiazolyl; a 2- indolyl; a 3-indolyl; a 2-(1-methyl)indolyl; a l-methyl-3-indolyl. The preferred s-substituted dithio group is represented by the 2-benzo thiazolyldithio radical of structure (c) in which R is 2-benzo thiazolyl.
The sulfonylthio group is preferably represented by the radical (d)
-S-Sθ2-R4 (d)
4 in which R is a (C.-C,)alkyl, an unsubstituted or substituted aryl or a unsubstituted or substituted heterocyclic group. In the radical (d) R advantageously represents methyl, ethyl, n-propyl, n-butyl, phenyl, phenyl substituted with a (C,-C^)alkyl, with a (C,-C.)alkoxy group, with a halogen or with a nitro group, 1-naphthyl, 2-naphthyl. The preferred sulfonylthio group is a radical of structure (d) in which R is p-methylphenyl, p-chlorophenyl, p-nitrophenyl or phenyl.
It is another object of the present invention to provide a process for the preparation of 2-(2-azetidinon-N-yl)-2 and 3-butenoic acids derivatives of formula I which comprises treating a 2-azetidinone of formula II
wherein X and Y are as defined above, with an ester of 2-bromo-3- butenoic acid of formula III CH =CH-CH-C0OR2 (III)
* I
Br wherein is as defined above, in a polar aprotic solvent at a temperature of from -40°C to +35°C in the presence of a base. The reaction is carried out using substantially equimolecular amounts of the compounds II and III, by adding compound III to the azetidinone II at low temperature, preferably between -40°C and -10°C in the selected solvent and by allowing the temperature to rise firstly at 0°C and then at room temperature.
The employed solvent may be a polar aprotic derivative such as N,N-dimethylacetamide, N,N-dimethylformamide, dimethylsulfoxide, acetonitrile and the like.
The base is used in eguimolecular amounts, but an excess in respect of the azetidinone II does not modify the course of the reaction. The employed base may be organic or inorganic, for example trimethylamine, triethylamine, N-methylmorpholine, N-methylpiperidine, N-benzyltrj. methylaπmonium hydroxide (hereinbelow designated Triton B), sodium hydride, sodium acetate.
When the reaction is over, the ester of the 2-(2-azetidinon-N-yl)- 2- and 3-butenoic acids thus obtained is isolated by neutralization of the excess of base.
The 2-azetidinones of formula II used as starting material for the preparation of the compounds of the present invention are known in the literature and can be prepared using well known methods.
The preparation of azetidinones of formula II in which X and Y, together, form a group (a), is described in Tetrahedron, 1983, 39, 2493-2503 or in J. Chem. Soc.
The preparation of 2-azetidinones of formula II in which X represents an acylamino group, more particularly a group of structure (b), and Y represents a S-substituted dithio group, more particularly a group of structure (c), is described in WO 84/00960.
The preparation of 2-azetidinones of formula II in which X represents an acylamino group, more particularly a group of structure (b) , and Y represents a substituted sulfonylthio group, more particularly a group of structure (d), is described in DE 3.443.225. The esters of 2-bromo-3-butenoic acid, corresponding to formula III, are prepared according to a method which comprises treating the 2-bromo-2-butenoyl chloride with the corresponding alcohol in the presence of a base in an apolar solvent.
The novel esters of the 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I are key intermediates for the preparation of cephem derivatives unsubst ituted in the 3-position .
It is a further object of the present invention to provide the use of the esters of the 2- ( 2-azetidinon-N-yl ) -2- and 3-butenoic acids corre sponding to the formu la I , for the preparation o f cephem derivatives unsubstituted in the 3-position of formula VIII
2 wherein X and R are as defined above.
Preferably, the present invention also provides the use of compounds of formula I above, wherein X represents a group of the structure (b) , for the preparation of cephem derivatives unsubstituted in the 3-position of formula IV
wherein R 1 and R2 are as defined above. For this use, the esters of the 2-(2-azetidinon-N-yl)-2- and 3- butenoic acids of formula I are subjected to a cyclization reaction.
The compounds of formula I, wherein X and Y, together, form a group (a) are firstly treated with an excess of 2-benzothiazolylsulfenyl chloride in dioxane/water at room temperature or with a slight excess of 2-benzothiazolyl disulfide in tetrahydrofurane in the presence of an aqueous acid such as 5% hydrochloric acid, 25+30% p-toluene sulfonic acid or 10+20% perchloric acid, still at room temperature, to obtain a compound of formula V
wherein X is acylamino and Y is a group of structure (c) in which R~ is 2-benzothiazolyle. Still starting from the novel compounds of formula I wherein X and Y, together, form a group of structure (a), the opening of the thiazoline ring is obtained by a reaction with a sulfonyl chloride, particularly with a compound of formula VI
R4-Sθ2-Br (VI) wherein R is as defined above, to afford a compound of formula VII
wherein X represents an acylamino group, more particularly a group of
2 structure (b), R represents a carboxy-protecting group and Z represents hydrogen, methyl, chloro or nitro. For example, the compound of formula I, wherein X and Y, together, form a group of structure (a), is treated with benzenesulfonyl bromide, p- toluenesulfonyl bromide or p-nitrobenzenesulfonyl bromide in a solvent such as methanol, acetone, tetrahydrofurane, methylene chloride or their mixtures at a temperature of 10+15°C to obtain the corresponding
2 compound of formula VII wherein X, and Z have the above-stated meaning.
The compounds of formula I wherein X represents an acylamino group, particularly a group of structure (b), and Y represents a substituted dithio group, particularly a group of structure (c), and preferably the compounds of formula V are straightforward transformed into the corresponding cephem derivatives, unsubstituted in the 3-position, of formula IV, by treatment with a base. The cyclization occurs in a polar aprotic solvent such as dimethylformamide, or in a ether solvent such as tetrahydrofurane or dioxane, by using a base such as gaseous ammonia, sodium or potassium acetate, triethylamine, sodium or potassium carbonate or bicarbonate, sodium or potassium hydroxide, 1,5-diazabicyclot5.4.0]undec-5-ene o tetramethylguanidine.
Analogously, the compounds of formula I wherein X represents an acylamino group, particularly a group of structure (b), and Y represents a sulfonylthio group, more particularly a group of structure (d) , and preferably the compounds of formula VII are straightforward transformed into the corresponding cefem derivatives, unsubstituted in the 3-position, by treatment with a base, as set forth for the compounds of formula V.
Thus, it is a further object of the present invention to provide a process for the preparation of 3-cephem derivatives unsubstituted in the 3-position of formula VIII
wherein X and are as defined above, which comprises
(a) treating an azetidinone of formula II
wherein X and Y are as defined above, with an ester of 2-bromo-3- butenoic acid of formula III
CH2=CH-CH-COOR2 (III)
Br
2 wherein R is as defined above, in a polar aprotic solvent in the presence of a base; and
(b) subjecting the ester of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids thus obtained of formula I
wherein the dotted lines indicate a double bond with 2- or 3-position,
2 X, Y and R are as defined above, to a cyclization n a basic medium.
Preferably as starting material a 2-azetidinone of formula II, wherein X represents a group of structure (b), is used, in order to obtain a cephem derivative, unsubstituted in the 3-position, of formula IV as final product. The following example illustrates the invention without, however, limiting it.
Esempio
[a] Benzyl 2-bromo-3-butenoate (III, R2= PhCH_)
A solution of 0.52 ml of benzyl alcohol and 1.39 ml of triethylami. ne in 5 ml of anhydrous ethyl ether is prepared at -78°C and under argon. After a 10-minute stirring, a solution of 1.38 g of 2-bromo-3- butenoyl chloride in 5 ml of anhydrous ethyl ether is added dropwise. After a 1-hour stirring the reaction mixture is treated with 5 ml of diluted HC1 (1:1 v/v);the aqueous phase is separated and extracted with 10 ml of ethyl ether. The combined ethereal phases are evaporated under vacuum to an oil.
Thus, 1.89 g of the oil sufficiently pure for the next step are obtained.
[b] Benzyl 2-(3-benzyl-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6- yl-7-oxo)-2-butenoate (I, X-Y=a, R1** PhCH2, R2=PhCH2).
To a solution of 2.18 of 3-benzyl-4-thia-2,6-diazabicyclo(3.2.0] hept-2-en-7-one in 100 ml of tetrahydrofurane, at 0°C, a suspension of 0.24 g of sodium hydride (80% oil dispersion) in 10 ml of tetrahydro furane are added. A solution of 2.39 g of benzyl 2-bromo-3-butenoate in 50 ml of tetrahydrofurane is slowly added. After a 24-hour stirring, the reaction mixture is treated with ice and extracted with 15 ml of ethyl acetate. The organic phase is separated, dried and evaporated under vacuum. The residue is purified by chromatography on a silica gel column (ethyl acetate/petroleum ether = 3:1 v/v) . After evaporation of the eluate under vacuum, 1.77 g of the desired product are obtained.
1H-NMR (300 MHz)(ppm): 1.56 (d, 3H, methyl); 3.90 (dd, 2H, CH2 benzyl); 5.18 (dd, 2H, CH2 ester); 6.04 (s, 2H, CH in 1 and 5); 7.0 (q, 1H, =CH); 7.27+7.37 (m, 10H, aromatic). [c] Benzyl 2-(l-azetidin-2-(2-benzothiazolylthio)-3-benzyl-4-oxo)- 2-butenoate (V, X = PhCH2CONH, R2= PhCH2)
4.32 g of benzothiazolyldisulfide are suspended in a mixture of 40 ml of tetrahydrofurane and 10 ml of 5% HC1. Under stirring, 3.92 g of the intermediate [b] are added and the obtained suspension is stirred at 18÷20°C per 1 hour. The obtained solution is partially evaporated, then diluted with 20 ml of methylene chloride. After concentration under vacuum of the separated organic phase, the residue is purified by column chromatography of silica gel, eluted with methylene chloride/ethyl acetate (3:2 v/v). The collected fractions are concentrated to afford 2.44 g of the desired product.
[d] Benzyl 2-[l-azetidin-2-(4-methylphenilsulfonylthio)-3-benzyl-4- oxo]-2-butenoate (VII, X = PhCH2CONH, R2= PhCH2, Z = CH3)
To a solution of 5.76 g of the intermediate [c] in 200 ml of a mixture acetone/water (9:1 v/v), in portions in 1 hour, 3.8 g of p- toluenesulfonyl bromide are added. The suspension is stirred for another hour, the insoluble residue is removed by filtration and the filtrate is evaporated under vacuum. The residue is extracted with 50 ml of ethyl acetate and the phases are separated; the organic phase is evaporated under vacuum to afford a oil. The residual oil is purified by chromatography on a silica gel column eluted with methylene chloride/ethyl acetate (3:1 v/v). The fractions containing the desired product are concentrated under vacuum to afford 3.88 g.
[e] Benzyl 7-phenylacetamido-8-oxo-5-thia-l-azabicyclo[4.2.0]oct-2- en-2-carboxylate (IV, R1** Ph, R2= PhCH2) To a solution of 2.88 g of the intermediate [c] in 150 ml of tetrahydrofurane, cooled to -65+-70°C, 1.5 g of DBU are added. After a 1-hour stirring at the same temperature the reaction mixture is acidified with 35% HC1, then diluted with 60 ml of ethyl acetate. The phases are separated and the organic one is washed with water and evaporated under vacuum to afford an oil. The residual oil is purified by chromatography on a silica gel colomn, eluted with methylene chloride/ethyl acetate (3:1 v/v). The collected fractions are evaporated to obtain 1.44 g of the desired product.
[f] Benzyl 7-phenylacetamido-8-oxo-5-thia-l-azabicyclo[4.2.0]oct-2- ene-2-carboxylate (IV, R1= Ph, R2= PhCH2)
To a solution of 2.13 of the intermediate [d] in 120 ml of tetrahydrofurane, 1.32 ml of DBU at 0÷+5°C are added. After a 2-hour stirring the temperature is let to reach to 20°c. By proceeding according to [e], 1.31 g of the desired product are obtained.

Claims

CLAIMS 1. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I
wherein X represents an acylamino group, Y represents a S-substituted dithio group or a sulfonylthio group, or X and Y, together, form a group (a)
in which R 1 represents the residue bond to the carbonyl of X and R2 represents a carboxy-protecting group.
2. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claim 1, in which X is a group of structure (b)
R1-CO-NH- (b) in which represents a phenyl, phenoxymethyl or benzyl radical, unsubstituted or substituted on the benzene ring with one or two atoms of a halogen, with one or two alkyl groups of from 1 to 4 carbon atoms, or with one or two alkoxy groups containing from 1 to 4 carbon atoms.
3. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claim 1, wherein X and Y, together, form a group of structure (a), in which R is as defined in claim 2.
4. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claims 1 to 3, wherein Y is a S-substituted dithio group of structure (c) -S-S-R3 (c) in which R is a phenyl, a phenyl substituted with a (C1~C4)alkyl, preferably methyl, with one or two atoms of a halogen, with a nitro group or with a (C,-C4)alkoxy group; a 1-naphthyl; a 2-naphthyl; a 6- methoxy-2-naphthyl; a 4-biphenylyl; a 2-benzimidazolyl; a 2- benzothiazolyl; a 2-indolyl; a 3-indolyl; a 2-(1-methyl)indolyl; a 1- methyl-3-indolyl.
5. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claims 1 to 4, wherein Y is a s-substituted dithio group of structure (c) in which R is 2-benzothiazolyl.
6. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claims 1 to 3, wherein Y is a sulfonylthio group of structure (d)
-S-Sθ2-R4 (d)
4 in which R represents methyl, ethyl, n-propyl, n-butyl, phenyl, phenyl substituted with a (C.-C*)alkyl, with a (C.-C.)alkoxy group, with a halogen or with a nitro group, 1-naphthyl, 2-naphthyl.
7. Esters of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claims 1 to 3 and 6, wherein Y is a
4 sulfonylthio group of structure (d) , in which R represents phenyl, p- methylphenyl, p-chloropheyl or p-nitrophenyl.
8. A process for the preparation of esters of 2-(2-azetidinon-N- yl)-2- and 3-butenoic acids of formula I according to claim 1, which comprises treating a 2-azetidinone of formula II
wherein X and Y are as defined in claim 1, with an ester of 2-bromo-3- butenoic acid of formula III
CH2=CH-CH-COOR2 (III)
Br
2 wherein R is as defined in claim 1, in a polar aprotic solvent at a temperature of from -40°C to +35°C in the presence of a base.
9. A process according to claim 8, in which sodium hydride is used as a base.
10. Use of esters of the 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I for the preparation of the corresponding cephem derivatives unsubstituted in the 3-position of formula VIII
wherein X and R are as defined in claim 1.
11. Use of esters of the 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids of formula I according to claims 2 to 7 for the preparation of cephem derivatives unsubstituted in the 3-position of formula IV
wherein R 1 is as defined in claim 2 and R 2 is as defined in claim 1.
12 . A process for the preparation of 3-cephem derivatives unsubstituted in the 3-position of formula VIII
2 wherein X and R are as defined in claim 1, which comprises:
(a) treating an azetidinone of formula II
wherein X and Y are as defined in claim 1, with an ester of 2-bromo-3- butenoic acid of formula III
CH-,«CH-CH-C0OR'
2 I (HI)
Br
2 wherein R is as defined in claim 1, in a polar aprotic solvent in the presence of a base; and
(b) subjecting the ester of 2-(2-azetidinon-N-yl)-2- and 3-butenoic acids thus obtained of formula I
wherein the dotted lines indicate a double bond with 2- or 3-position,
2 X, Y and R are as defined in claim 1, to a cyclization in a basic medium.
13. A process according to claim 11, in which a 2-azetidinone of formula II, wherein X is a group of structure (b)
R1-CO-NH- (b) in which R represents a phenyl, phenoxymethyl or benzyl radical, unsubstituted or substituted on the benzene ring with one or two atoms of a halogen, with one or two (C.-C.)alkyl groups or with one or two
(C.-C.Jalkoxy groups is used as starting material.
EP95927711A 1994-07-22 1995-07-21 2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis Withdrawn EP0773928A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI941554A IT1270995B (en) 1994-07-22 1994-07-22 2- (2-AZETIDINON-N-IL) -3-BUTENOIC ACID DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF Cephalosporins
ITMI941554 1994-07-22
PCT/EP1995/002911 WO1996003373A1 (en) 1994-07-22 1995-07-21 2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis

Publications (1)

Publication Number Publication Date
EP0773928A1 true EP0773928A1 (en) 1997-05-21

Family

ID=11369339

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95927711A Withdrawn EP0773928A1 (en) 1994-07-22 1995-07-21 2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis

Country Status (5)

Country Link
EP (1) EP0773928A1 (en)
JP (1) JPH10503190A (en)
AU (1) AU3164895A (en)
IT (1) IT1270995B (en)
WO (1) WO1996003373A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445822B1 (en) * 1990-03-08 1997-06-04 Otsuka Kagaku Kabushiki Kaisha Thiazolinoazetidinone derivative and process for preparing 2-exo-methylene-penam derivative thereform
JP2993576B2 (en) * 1991-03-11 1999-12-20 大塚化学株式会社 Allenyl β-lactam compound and method for producing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9603373A1 *

Also Published As

Publication number Publication date
IT1270995B (en) 1997-05-26
WO1996003373A1 (en) 1996-02-08
AU3164895A (en) 1996-02-22
JPH10503190A (en) 1998-03-24
ITMI941554A0 (en) 1994-07-22
ITMI941554A1 (en) 1996-01-22

Similar Documents

Publication Publication Date Title
US4071512A (en) Preparation of 1-oxapenicillins and intermediates therefor
US4115643A (en) Process for 3-chloro cephalosporins
US4237051A (en) Stereospecific production of 6- or 7-carbon-substituted-β-lactams
CH623331A5 (en) Process for the preparation of 7beta-amino- and 7beta-acylamino-6alphaH-8-oxo-4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-ca rboxylic acid derivatives
EP0773928A1 (en) 2-(2-azetidinon-n-yl)-2- and 3-butenoic acids derivatives and their use in the cephalosporine synthesis
US4159266A (en) Method of preparation of 3-methylenecephams
DE2429166A1 (en) PROCESS FOR THE SELECTIVE SPLITTER OF THE AMIDIC ACID FUNCTION OF A 7- (AMIDIC ACID) CEPHALOSPORINE
US4103086A (en) 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
US4008230A (en) Process for preparing 3-hydroxy cephalosporins
CA1146538A (en) Process for chemically removing the acyl side-chain from cephalosporins and penicillins
US4036835A (en) Process for preparing cephalosporins
US4665166A (en) Process for preparing cephalosporin compounds
KR870000528B1 (en) Process for preparing 3-azidocephalosporins
US4379923A (en) Preparation of 7-acylamino-3-(thio-substituted)-methyl 3-cephem-4-carboxylic acid-1-oxide derivatives
EP0132395B1 (en) Improvements in or relating to the preparation of azetidinone sulfinic acids from cephalosporin sulfones
US4115383A (en) Alkoxycarbonyl-ethylthio-azetidinones and process for their preparation
US4336191A (en) Penicillin conversion by halogen electrophiles and anti-bacterials derived thereby
KR860001364B1 (en) Process for preparing 7-epi-3-exomethylenecepham derivatives
US4656264A (en) Bicyclic azetidinone intermediates
US3985746A (en) 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
JP2545225B2 (en) Optically active hydantoin compound
US6348454B1 (en) Syntheses of new isodethiaazacephems and isodethiaazacephams, and use as potent antibacterial agents
DE2615621A1 (en) Beta-lactam antibiotics - and beta-lactam precursors of penicillins and cephalosporins
US4394313A (en) Symmetrical azetidinone aldehyde disulfides and process
US4293495A (en) Symmetrical azetidinone aldehyde disulfides and process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK FR GB IE IT LI LU NL PT SE

17P Request for examination filed

Effective date: 19970225

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990202